Charles Marlowe, Phd work email
- Valid
- Valid
- Valid
Charles Marlowe, Phd personal email
Offers consulting to startup and later stage biotechnology and pharmaceutical companies specializing in small molecule therapeutics: lead identification, validation, optimization, chemical design and synthesis, SAR analysis as well as therapeutic candidate identification/selection through review of ADME, PK and PD data, followed by process development, and technical transfer to competent CROs or internal groups. Expert opinion on intellectual property identification, structural landscape, and chemical patent preparation as well. Technical transfer of synthetic processes, management of Contract Research Organizations and pre-IND enabling documentation also supported.Clinical candidates: http://en.wikipedia.org/wiki/Elinogrel and XL147 (also known as SAR245408)http://en.wikipedia.org/wiki/Phosphoinositide_3-kinase_inhibitor
-
Co-FounderBaymedica Inc Aug 2016 - PresentBayMedica's world class scientific team has developed an efficient and scalable yeast-based biosynthesis platform for cannabinoids. Their disruptive, patent-pending technology enables the manufacture of both naturally occurring and novel pharmaceutical-grade cannabinoids, with a lower cost than that of plant-derived cannabinoids. BayMedica is extremely well positioned to take advantage of the projected explosive pharmaceutical cannabinoid science market.
-
PrincipalPharmaceutical Consultants Mar 2010 - PresentOffers consulting to startup and later stage biotechnology and pharmaceutical companies specializing in small molecule therapeutics: lead identification, validation, optimization, chemical design and synthesis, SAR analysis as well as therapeutic candidate identification/selection through review of ADME, PK and PD data, followed by process development, and technical transfer to competent CROs or internal groups. Expert opinion on intellectual property identification, structural landscape, and chemical patent preparation as well. Technical transfer of synthetic processes, management of Contract Research Organizations and pre-IND enabling documentation also supported. -
Assoc. Director Medicinal ChemistryExelixis Oct 2003 - Mar 2010Alameda, California, Us -
Senior Ii Scientist Medicinal ChemistryMillennium Pharmaceuticals 2002 - 2003Cambridge, Ma, Us -
Senior Scientist Medicinal ChemistryCor Therapeutics/Millennium Sf 2001 - 2002
-
Senior Scientist Medicinal ChemistryCor Therapeutics 1993 - 2001
-
Scientist IiChiron Corporation 1989 - 1993Emeryville, California, Us -
ScientistDow Agrosciences 1988 - 1989Indianapolis, In, Us
Charles Marlowe, Phd Skills
Charles Marlowe, Phd Education Details
-
Stanford UniversityOrganic Chemistry -
University Of California, BerkeleySynthetic & Bioorganic -
Uc IrvineChemistry/Biology
Frequently Asked Questions about Charles Marlowe, Phd
What company does Charles Marlowe, Phd work for?
Charles Marlowe, Phd works for Pharmaceutical Consultants
What is Charles Marlowe, Phd's role at the current company?
Charles Marlowe, Phd's current role is Baymedica Inc.
What is Charles Marlowe, Phd's email address?
Charles Marlowe, Phd's email address is ck****@****msn.com
What schools did Charles Marlowe, Phd attend?
Charles Marlowe, Phd attended Stanford University, University Of California, Berkeley, Uc Irvine.
What skills is Charles Marlowe, Phd known for?
Charles Marlowe, Phd has skills like Medicinal Chemistry, Biotechnology, Chemistry, Drug Discovery, Drug Development, Hplc, Life Sciences, Pharmaceutical Industry, Drug Metabolism, Oncology, Clinical Development, Organic Chemistry.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial